Abstract
The adenovirus E4orf6 is a viral oncoprotein known to cooperate with the E1A gene product in transforming primary murine cells. It has been shown to inhibit the apoptotic activities of p53 and p73 through direct binding to these proteins. Here, we demonstrate that the adenovirus E4orf6 protein inhibits apoptosis mediated by BNIP3 and Bik, which are BH3-only proteins of the Bcl-2 family. This activity was not mediated by p53 and p73 because E4orf6 had the same effect on the apoptosis in Saos-2 cells that do not express p53-related genes. It was also ascertained that E4orf6 could change the mitochondrial localization of BNIP3 and Bik. A mutant lacking the nuclear export signal of E4orf6 failed to inhibit apoptosis and to translocate BNIP3 protein from the mitochondria. Moreover, it was also established that E4orf6 was able to interact with BNIP3 and Bik. In BNIP3 protein, the region required for the interaction included the transmembrane domain, which is required for the localization of BNIP3 to the mitochondria. These results suggest that E4orf6 is exported from the nucleus to the cytoplasm, enabling it to interact with BH3-only proteins, eventually leading to the inhibition of apoptotic activity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstron S, Avery BJ, Ebb RG, Subramanian T, Chittenden T, Luts RJ and Chinnadurai G . (1995). Oncogene, 11, 1921–1928.
Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B, D'Sa-Eipper C and Chinnanurai G . (1994). Cell, 79, 341–351.
Chandar N, Billig B, McMaster J and Nozak J . (1992). Br. J. Cancer, 65, 208–214.
Chen G, Ray R, Dubik D, Shi L, Cizeau J, Bleackley RC, Saxena S, Gietz RD and Greenberg AH . (1997). J. Exp. Med., 186, 1975–1983.
Cizeau J, Ray R, Chen G, Gietz RD and Greenberg AH . (2000). Oncogene, 19, 5453–5463.
Dobbelstein M, Roth J, Kimberly WT, Levine AJ and Shenk T . (1997). EMBO J., 16, 4276–4284.
Dobner T, Horikoshi N, Rubenwolf S and Shenk T . (1996). Science, 272, 1470–1473.
Dosch T, Horn F, Schneider G, Kratzer F, Dobner T, Hauber J and Stauber RH . (2001). J. Virol., 75, 5677–5683.
Fischer N, Voss MD, Mueller-Lantzsch N and Grasser FA . (1999). FEBS Lett., 447, 311–314.
Goodrum FD, Shenk T and Ornelles DA . (1996). J. Virol., 70, 6323–6335.
Green DR and Reed JC . (1998). Science, 281, 1309–1312.
Gross A, McDonnell JM and Korsmeyer SJ . (1999). Genes Dev., 13, 1899–1911.
Halbert DN, Cutt JR and Shenk T . (1985). J. Virol., 56, 250–257.
Harlow E, Whyte P, Franza R and Schley C . (1986). Mol. Cell. Biol., 6, 1579–1589.
Higashino F, Pipas JM and Shenk T . (1998). Proc. Natl. Acad. Sci. USA, 95, 15683–15687.
Huang DC and Strasser A . (2000). Cell, 103, 839–842.
Ishida S, Yamashita Y, Nakaya U and Tokino T . (2000). Jpn. J. Cancer Res., 91, 174–180.
Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D . (1997). Cell, 90, 809–819.
Kim JY, Cho JJ, Ha J and Park JH . (2002). Arch. Biochem. Biophys., 398, 147–152.
Kubasiak LA, Hernandez OM, Bishopric NH and Webster KA . (2002). Proc. Natl. Acad. Sci. USA, 99, 12825–12830.
Marton MJ, Baim SB, Ornelles DA and Shenk T . (1990). J. Virol., 64, 2345–2359.
Miyashita T and Reed JC . (1995). Cell, 80, 293–239.
Moore M, Horikoshi N and Shenk T . (1996). Proc. Natl. Acad. Sci. USA, 93, 11295–11301.
Nakano K and Vousden KH . (2001). Mol. Cell, 7, 683–694.
Nevels M, Rubenwolf S, Spruss T, Wolf H and Dobner T . (1997). Proc. Natl. Acad. Sci. USA, 94, 1206–1211.
Nevels M, Rubenwolf S, Spruss T, Wolf H and Dobner T . (2000). J. Virol., 74, 5168–5181.
Nevels M, Spruss T, Wolf H and Dobner T . (1998). Oncogene, 18, 9–17.
Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T and Tanaka N . (2000). Science, 288, 1053–1058.
Orlando JS and Ornelles DA . (1999). J. Virol., 73, 4600–4610.
Querido E, Blanchette P, Yan Q, Kamura T, Morrison M, Boivin D, Kaelin WG, Conaway RC, Conaway JW and Branton PE . (2001). Genes Dev., 15, 3104–3117.
Querido E, Marcellus RC, Lai A, Charbnneau R, Teodoro JG, Ketner G and Branton PE . (1997). J. Virol., 71, 3788–3798.
Ray R, Chen G, Vande Velde C, Cizeau J, Park JH, Reed JC, Giets RD and Greenberg AH . (2000). J. Biol. Chem., 275, 1439–1448.
Reed JC . (1995). J. Cell. Biol., 124, 1–6.
Sarnow P, Hearing P, Anderson CW, Halbert DN, Shenk T and Levine AJ . (1984). J. Virol., 49, 692–700.
Sarnow P, Ho YS, Williams J and Levine AJ . (1982). Cell, 28, 387–394.
Steegenga WT, Riteco N, Jochemsen AG, Fallanx FJ and Bos JL . (1998). Oncogene, 16, 349–357.
Teodoro JG and Branton PE . (1997). J. Virol., 71, 1739–1746.
Tsujimoto Y and Shimizu S . (2000). FEBS Lett., 466, 6–10.
Vande Velde C, Cizeau J, Dubik D, Alimonti J, Brown T, Israels S, Hakem R and Greenberg AH . (2000). Mol. Cell. Biol., 20, 5454–5468.
Weigel S and Dobbelstein M . (2000). J. Virol., 74, 764–772.
Weinberg DH and Ketner G . (1986). J. Virol., 57, 833–838.
Yasuda M, Theodrakis P, Subramanian T and Chinnadurai G . (1998). J. Biol. Chem., 273, 12415–12421.
Yu J, Zhang L, Hwang PM, Kinzler KW and Vogelstein B . (2001). Mol. Cell, 7, 673–682.
Acknowledgements
We thank G Chinnadurai for BNIP3 plasmid, T Shenk for the antibody for E4orf6 (RSA♯3) and E4orf6 plasmid and I Matsuoka for technical support. This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan, and by a Grant-in Aid from the Akiyama Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aoyagi, M., Higashino, F., Yasuda, M. et al. Nuclear export of adenovirus E4orf6 protein is necessary for its ability to antagonize apoptotic activity of BH3-only proteins. Oncogene 22, 6919–6927 (2003). https://doi.org/10.1038/sj.onc.1206743
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206743
Keywords
This article is cited by
-
Viral-mediated stabilization of AU-rich element containing mRNA contributes to cell transformation
Oncogene (2011)
-
HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cells
British Journal of Cancer (2009)